Serum cystatin C as a biomarker for early diabetic kidney disease and dyslipidemia in young type 1 diabetes patients

I Stankute, L Radzeviciene, A Monstaviciene… - Medicina, 2022 - mdpi.com
Background and objectives: This study aimed to assess the clinical significance of serum
cystatin C in the early diagnosis of renal injury and its association with dyslipidemia in young …

Is cystatin C a useful marker in the detection of diabetic kidney disease?

RL Borges, AH Hirota, BMR Quinto, AB Ribeiro… - Nephron Clinical …, 2010 - karger.com
Abstract Background/Aims: To evaluate cystatin C as a marker of diabetic kidney disease in
normoalbuminuric diabetic patients without chronic kidney disease (CKD). Methods: A cross …

Evaluation of serum cystatin c as an indicator of early renal function decline in type 2 diabetes

AA Shohaib, AS Seleem, HE Barbary… - Menoufia Medical …, 2014 - menoufia-med-j.com
Objectives This study was conducted to evaluate the clinical usefulness of cystatin C levels
in the serum in predicting renal impairment in patients with type 2 diabetes. Background In …

Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.

YL Jeon, MH Kim, WI Lee, SY Kang - Clinical Laboratory, 2013 - europepmc.org
BACKGROUND: Serum cystatin C has been proposed as an endogenous marker of
glomerular filtration rate (GFR) because it shows a correlation with the albumin to creatinine …

Early detection of renal impairment among patients with type 2 diabetes mellitus through evaluation of serum cystatin C in comparison with serum creatinine levels: a …

T Asmamaw, S Genet, M Menon… - Diabetes, Metabolic …, 2020 - Taylor & Francis
Background The proportion of patients with end-stage renal disease caused by diabetes has
progressively increased during the last few decades. Serum creatinine level is the most …

Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus

MS Elsayed, A El Badawy, R Omar… - Diabetes & Metabolic …, 2019 - Elsevier
Background Diabetes mellitus (DM) refers to a group of common metabolic disorders that
share the phenotype of hyperglycemia. The metabolic dysregulations associated with DM …

Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients

M Hassan, MM Aboelnaga, M Al-Arman… - Diabetes & Metabolic …, 2021 - Elsevier
Aims We aimed to evaluate urinary CysC (cystanin c) as an early marker of diabetic
nephropathy in patients with type 2 diabetes and investigate the correlation of urinary CysC …

Diagnostic accuracy of serum cystatin C for early recognition of nephropathy in type 2 diabetes mellitus

S Sapkota, S Khatiwada, S Shrestha… - International Journal …, 2021 - Wiley Online Library
Objectives. Diabetic nephropathy is one of the major complications that develop over time in
type 2 diabetes mellitus (T2DM). This prospective study was conducted to assess the …

[PDF][PDF] Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients.

AAK Al-Saedy, KM Turki, SZ Nada - Journal of Contemporary Medical …, 2017 - iasj.net
Objective This study aimed to find the effect of serum Cystatin C in early diabetic
nephropathy. Method This study was conducted in Al Kindy Teaching Hospital during the …

Serum cystatin C an early indicator of renal function decline in type 2 diabetes

HS Elbarbary, NA El-Kafrawy, AA Shoaib… - American Journal of …, 2014 - ajisat.org
Objectives: evaluation of cystatin C level in the serum as a predictor of early renal
impairment in type 2 diabetic patients. Background: the glomerular filtration rate (GFR) is …